Early serum PreS1 levels are predictive of HBsAg loss in interferon-alpha treated children with HBeAg-positive chronic hepatitis B
Peiyao Fan(Peking University), Min Zhang(British Heart Foundation), Yanwei Zhong, Jianguo Yan(Ministry of Education of the People's Republic of China), Fuchuan Wang(302 Military Hospital of China), Zhi‐Qiang Xu(Nanjing Medical University), Yi Dong(XinHua Hospital), Yinjie Gao(Chinese PLA General Hospital), Lili Cao(Chinese PLA General Hospital)
Cited by 0
Related Papers
Nano Ultrasound Contrast Agent for Synergistic Chemo‐photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis
|Advanced Science|2023|96
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study
|Journal of Hepatology|2018|85
Effect of pu‐erh tea on body fat and lipid profiles in rats with diet‐induced obesity
|Phytotherapy Research|2010|72
Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample
|Hepatology|2015|70
Treatment with Huperzine A Improves Cognition in Vascular Dementia Patients
|Cell Biochemistry and Biophysics|2011|58